@ the Bell: Markets slide as Iran-Israel conflict deepens
On Monday evening, US President Donald Trump posted on his social media platform, urging, 'Everyone should immediately evacuate Tehran.' He also left the G7 summit in Canada ahead of schedule to address the unfolding Middle East crisis.
US markets also saw a downturn as investors closely monitored the intensifying conflict between Israel and Iran.
In an unexpected announcement, Prime Minister Mark Carney revealed that he and Trump had agreed to pursue a new economic and security agreement between their countries, aiming to finalize it within 30 days.
The Canadian dollar traded for 73.19 cents US compared to 73.77 cents US on Monday.
US crude futures traded US$3.33 higher at US$75.10 a barrel, and the Brent contract rose US$3.46 to US$76.69 a barrel.
The price of gold was down US$12.88 to US$3,384.76.
In world markets, the Nikkei was up 225.41 points to ¥38,536.74, the Hang Seng was down 80.69 points to HK$23,980.30 the FTSE was down 41.19 points to ₤8,834.03, and the DAX was down 264.47 points to €23,434.65.
The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Toronto Sun
an hour ago
- Toronto Sun
Letters to the Editor, July 3, 2025
TAKE A SEAT LIBS First you Liberals elected Mark Carney because he was the best of the worst. Now you have the media gloating on how Carney is reacting to the tensions of the Middle East. Note to Liberals: Carney is a banker and nothing else. He and his cabinet know nothing about world affairs and do not know how to deal with them. You have no clout. You have no influence, and to be frank, no one takes you seriously! So please stop the charade and do what you do best by continuing to rack up debt! Rick Dwornikiewicz Delhi, Ont. (Carney's cabinet is amateur hour when it comes to international affairs — but we would prefer them not to keep spending the way they do and increasing the debt) LEADERSHIP FAIL As a proud Canadian senior l am very distressed and disheartened at the lack of performance of our political leaders. Whether it be Mayor Olivia Chow or Prime Minister Mark Carney, the interests of the citizens they are paid to care for are often neglected. Chow, like Justin Trudeau, seems more concerned with dressing up like a court jester at every event, while Carney seems to be allergic to telling the truth. These are serious times, and our leaders need to perform accordingly. Michael Leonard Florio Brampton (It was inevitable Carney was going to turn out to be a giant disappointment, too bad more Canadians didn't see this a couple of months ago) COMING OF WAR If, as American author Randolph Bourne averred, 'War is the health of the state,' then the U.S., Israel, Iran and God knows what other nations are soon to become embroiled in yet another futile unwinnable forever war over weapons of mass destruction that will, allegedly, leave them a whole lot better off for it. Those able to juggle such contradiction with nimble Trumpian dexterity won't be put off by absence of logic in this state of affairs while they blithely square the circle. Orest Slepokura Calgary (Hamas started the war with Israel — Iran funded Hamas and Israel has the right to defend itself by all means necessary. The precision with which Israel has dismantled Iran's leadership and military capabilities — and the U.S. with the bunker busters — is exactly why there won't be a long drawn out war) This advertisement has not loaded yet, but your article continues below. THIS CONTENT IS RESERVED FOR SUBSCRIBERS ONLY Subscribe now to read the latest news in your city and across Canada. Unlimited online access to articles from across Canada with one account. Get exclusive access to the Toronto Sun ePaper, an electronic replica of the print edition that you can share, download and comment on. Enjoy insights and behind-the-scenes analysis from our award-winning journalists. Support local journalists and the next generation of journalists. Daily puzzles including the New York Times Crossword. SUBSCRIBE TO UNLOCK MORE ARTICLES Subscribe now to read the latest news in your city and across Canada. Unlimited online access to articles from across Canada with one account. Get exclusive access to the Toronto Sun ePaper, an electronic replica of the print edition that you can share, download and comment on. Enjoy insights and behind-the-scenes analysis from our award-winning journalists. Support local journalists and the next generation of journalists. Daily puzzles including the New York Times Crossword. REGISTER / SIGN IN TO UNLOCK MORE ARTICLES Create an account or sign in to continue with your reading experience. Access articles from across Canada with one account. Share your thoughts and join the conversation in the comments. Enjoy additional articles per month. Get email updates from your favourite authors. THIS ARTICLE IS FREE TO READ REGISTER TO UNLOCK. Create an account or sign in to continue with your reading experience. Access articles from across Canada with one account Share your thoughts and join the conversation in the comments Enjoy additional articles per month Get email updates from your favourite authors Don't have an account? Create Account Sports News Money News MLB Editorial Cartoons
Cision Canada
an hour ago
- Cision Canada
LSL PHARMA GROUP ANNOUNCES REDEMPTION OF 11% UNSECURED CONVERTIBLE DEBENTURES
BOUCHERVILLE, QC, July 2, 2025 /CNW/ - LSL PHARMA GROUP INC. (TSXV: LSL) (" LSL Pharma" or the " Corporation"), a Canadian integrated pharmaceutical company, is pleased to announce that TSX Trust Company (the " Trustee"), in accordance with the trust indenture dated November 1, 2023 between the Corporation and the Trustee (the " Indenture"), will be providing notice of early redemption of all of the Corporation's outstanding $3,288,000 aggregate principal amount of 11% convertible unsecured convertible debentures, originally due October 31, 2028 (the " Convertible Debentures"). The Convertible Debentures will be redeemed by the Trustee on August 4, 2025 (the " Redemption Date"), in accordance with the terms of the Indenture. The Convertible Debentures, which are listed and posted for trading on the TSX Venture Exchange (" TSXV") under the symbol will cease trading on the Redemption Date, in accordance with TSXV policies. On the Redemption Date, the Trustee will pay holders of Convertible Debentures a redemption price equal to $10.40 for each $10 principal amount of Convertible Debentures (which includes the early repayment premium required pursuant to the Indenture) plus all accrued and unpaid interest up to but excluding the Redemption Date. Beneficial holders of the Convertible Debentures are encouraged to contact their investment dealer to coordinate the surrender of their Convertible Debentures or if they have any questions about the redemption. No action is required to be taken by holders of the Convertible Debentures in connection with the redemption. ABOUT LSL PHARMA GROUP INC. LSL Pharma Group Inc. is a Canadian integrated pharmaceutical company specializing in the development, manufacturing and commercialization of high-quality sterile ophthalmic pharmaceutical products, as well as pharmaceutical, cosmetic and natural health products in solid, semi-solid and liquid dosage forms. Companies forming part of LSL Pharma Group include Steri-Med Pharma Inc., LSL Laboratory Inc., Virage Santé Inc. and Dermolab Pharma Ltd. For further information, please visit our website at CAUTION REGARDING FORWARD-LOOKING STATEMENTS This press release may contain forward-looking statements as defined under applicable Canadian securities legislation. Forward-looking statements can generally be identified by the use of forward-looking terminology such as "may", "will", "expect", "intend", "estimate", "continue" or similar expressions. Forward-looking statements are based on a number of assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond the Corporation's ability to control or predict, that could cause actual results or performance to differ materially from those expressed or implied in such forward-looking statements. These risks and uncertainties include, but are not limited to, those identified in the Corporation's filings with Canadian securities regulatory authorities, such as legislative or regulatory developments, increased competition, technological change and general economic conditions. All forward-looking statements made herein should be read in conjunction with such documents. Readers are cautioned not to place undue reliance on forward-looking statements. No assurance can be given that any of the events referred to in the forward-looking statements will transpire, and if any of them do, the actual results, performance or achievements of the Corporation may differ materially from those expressed or implied by the forward-looking statements. All forward-looking statements contained in this press release speak only as of the date of this press release. The Corporation does not undertake to update these forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) have reviewed or accept responsibility for the adequacy or accuracy of this release. SOURCE Groupe LSL PHARMA INC.
CBC
an hour ago
- CBC
Trump likes 'humiliating' countries: Former NAFTA negotiator
Canada's chief negotiator for the original NAFTA, John Weekes, doesn't think the White House claim that Canada 'caved' has had much impact on Canada's position in talks with the U.S., arguing President Donald Trump 'likes to show that he's humiliating the countries he's negotiating with.' Weekes argues the relationship could be the most uncertain it's been since the Second World War.
